Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-small-Cell Lung Cancer: Optimizing Outcomes throughout the Trajectory of Care

被引:0
作者
Schmid, S. [1 ]
Minnella, E. M. [2 ]
Pilon, Y. [2 ]
Rokah, M. [2 ]
Rayes, R. [2 ]
Najmeh, S. [2 ]
Cools-Lartigue, J. [2 ]
Ferri, L. [2 ]
Mulder, D. [2 ]
Sirois, C. [2 ]
Owen, S. [2 ]
Shieh, B. [2 ]
Ofiara, L. [2 ]
Wong, A. [2 ]
Sud, S. [3 ]
Baldini, G. [2 ]
Carli, F. [2 ]
Spicer, J. [2 ]
机构
[1] Univ Freiburg, Med Ctr, Freiburg, Germany
[2] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[3] Ctr Integre Sante & Serv Sociaux Outaouais, Gatineau, PQ, Canada
关键词
Prehabilitation; neoadjuvant therapy; exercise program;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP05.02-01
引用
收藏
页码:S289 / S289
页数:1
相关论文
共 50 条
  • [41] Multimodal prehabilitation in patients with non-small cell lung cancer: a feasibility study
    ten Cate, David W. G.
    van den Berg, Rosaline
    Scholten-Bakker, Maaike
    Molenaar, Charlotte J. L.
    von Meyenfeldt, Erik M.
    Slooter, Gerrit D.
    van den Broek, Frank J. C.
    Marres, Geertruid M. H.
    JOURNAL OF THORACIC DISEASE, 2024, 16 (05) : 2776 - +
  • [42] Management of locally advanced non-small cell lung cancer: state of the art and future directions
    Miao, Da
    Zhao, Jing
    Han, Ying
    Zhou, Jiaqi
    Li, Xiuzhen
    Zhang, Ting
    Li, Wen
    Xia, Yang
    CANCER COMMUNICATIONS, 2024, 44 (01) : 23 - 46
  • [43] Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer
    Naito, Tateaki
    Mitsunaga, Shuichi
    Miura, Satoru
    Tatematsu, Noriatsu
    Inano, Toshimi
    Mouri, Takako
    Tsuji, Tetsuya
    Higashiguchi, Takashi
    Inui, Akio
    Okayama, Taro
    Yamaguchi, Teiko
    Morikawa, Ayumu
    Mori, Naoharu
    Takahashi, Toshiaki
    Strasser, Florian
    Omae, Katsuhiro
    Mori, Keita
    Takayama, Koichi
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (01) : 73 - 83
  • [44] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [45] Outcomes of Lobar and Sublobar Resections for Non-Small-Cell Lung Cancer: A Single-Center Experience
    Kim, Daniel
    Ferraris, Victor A.
    Davenport, Daniel
    Saha, Sibu
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (04) : 230 - 234
  • [46] Neoadjuvant therapy in non-small cell lung cancer.: Prognostic impact of "mediastinal downstaging"
    Langner, K
    Thomas, M
    Klinke, F
    Bosse, U
    Heinecke, A
    Müller, KM
    Junker, K
    CHIRURG, 2003, 74 (01): : 42 - 48
  • [47] Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816
    Mitsudomi, Tetsuya
    Ito, Hiroyuki
    Okada, Morihito
    Sugawara, Shunichi
    Shio, Yutaka
    Tomii, Keisuke
    Okami, Jiro
    Sakakura, Noriaki
    Kubota, Kaoru
    Takamochi, Kazuya
    Atagi, Shinji
    Tsuboi, Masahiro
    Oizumi, Satoshi
    Ikeda, Norihiko
    Ohde, Yasuhisa
    Ntambwe, Ives
    Mahmood, Javed
    Cai, Junliang
    Tanaka, Fumihiro
    CANCER SCIENCE, 2024, 115 (02) : 540 - 554
  • [48] Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer
    Bao, Xiao
    Bian, Dongliang
    Yang, Xing
    Wang, Zheming
    Shang, Mingdong
    Jiang, Gening
    Shi, Jingyun
    EUROPEAN RADIOLOGY, 2023, 33 (12) : 9182 - 9193
  • [49] Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer
    Xiao Bao
    Dongliang Bian
    Xing Yang
    Zheming Wang
    Mingdong Shang
    Gening Jiang
    Jingyun Shi
    European Radiology, 2023, 33 : 9182 - 9193
  • [50] Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
    Zhao, Guangyin
    Zhang, Hongyu
    Xu, Fengkai
    Lu, Chunlai
    Zhu, Qiaoliang
    Grossi, Francesco
    Divisi, Duilio
    Ma, Teng
    Gu, Jie
    Ge, Di
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 141 - 149